News you can use: health & drug safety updates


  • January 31, 2018

    FDA announced Tuesday a new action to combat the increasing problem of misuse and abuse of the OTC antidiarrheal drug loperamide. When used at very high and dangerous doses, the drug may be used by some individuals as a way to manage opioid withdrawal symptoms or to achieve the euphoric effects of opioid use. FDA is requesting that manufacturers of OTC loperamide "change the way they label and package these drugs to stem abuse and misuse that leaves us deeply concerned," FDA Commissioner Scott Gottlieb, MD, said.

  • January 19, 2018

    New research shows that the number of privately insured U.S. women aged 15–44 years who filled a prescription for an ADHD drug rose 344% between 2003 and 2015, from 0.9% to 4%. According to the study, the number of women aged 25–29 years who filled an ADHD prescription increased by 700%, while there was a 560% increase among women aged 30–34 years.

  • January 12, 2018

    FDA announced safety labeling changes to limit the use of prescription opioid cough and cold medicines containing codeine or hydrocodone in children younger than age 18 years, saying the risks of the medicines outweigh their potential benefits.  Per FDA, After safety labeling changes are made, these products will no longer be indicated for use to treat cough in any pediatric population and will be labeled for use only in adults aged 18 years and older.

  • January 10, 2018

    NIDA offers several interactive ways to share the facts about the consequences of drug and alcohol use on the brain, body, and behavior. Be sure to register your event or activity to be visible on the national map of participants and to order free materials for your activity from NIDA by January 15 to get them in time for National Drug and Alcohol Facts Week, January 22 – 28.

  • January 5, 2018

    At a time when public- and private-sector leaders are seeking a substantial increase in government funding for opioid-addiction treatment programs and legislation requiring insurers to offer coverage for these treatments, polls show a large share of the public uncertain about the long-term effectiveness of treatment. Over the next few years, this impression could affect family referrals to treatment programs, as well as public support for them and for a government requirement that insurance cover their cost. There is a clear need for the medical and scientific communities to educate the public about the issues surrounding the potential effectiveness of treatment.

  • January 2, 2018

    A podcast presented by the Collegiate Recovery Community at The Ohio State University, discusses diversifying collegiate recovery communities with guest speaker Keith Murphy, a Recovery Counselor with the Alcohol and Other Drug Assistance Program at Rutgers University.   

  • January 1, 2018

    NCPIE serves as co-editor for a monthly column in Pharmacy Today (American Pharmacists Association) The column is entitled “One-to-One” and is intended to help develop pharmacists’ medication communication and counseling skills to promote safe and appropriate medicine use.


  • December 22, 2017

    If you are involved in the production, sales, and marketing of pharmaceutical packaging, keep in touch with the latest developments and thinking in making packs patient friendly.  Essential knowledge and experience in enhancing patient adherence through the use of innovative packaging can be found in the HCPC Europe quarterly newsletter.

  • December 20, 2017

    Millions of people depend on anticoagulants – also known as “blood thinners” – to prevent life-threatening blood clots. While these medications do not actually “thin” the blood, they do slow the body’s ability to form dangerous blood clots, such as blood clots in the arms or legs (deep vein thrombosis or DVT) and blood clots in the lungs (pulmonary embolism or PE). Blood thinners, however, do not completely stop the body’s ability to clot, because blood clots are a beneficial part of healing from an injury.

  • December 18, 2017

    Flu activity tends to peak between December and February. The Acetaminophen Awareness Coalition reminds consumers to double-check medicine labels to avoid doubling up on medicines that contain acetaminophen when treating illnesses during this cold and flu season. Acetaminophen is a common drug ingredient found in more than 600 over-the-counter and prescription medications. The FDA recommends taking no more than 4,000 milligrams of acetaminophen in a 24-hour period. Taking more than directed is an overdose and can lead to liver damage. (Source: AWARXE® Prescription Drug Safety Program, 12/18/17